-
A Dose of PrecisionStereotactic radiation therapy–heavily marketed to consumers–is gaining momentum as a more convenient treatment. But it's not for every patient.
by Sharon Reynolds
-
Healthy Habits
A Cup of Tea?Black tea consumption may be associated with a reduced risk of ovarian cancer.
by Kurt Ullman
-
Forward Look
A Champion for PreventionQ&A with Elmer Huerta, the director of the Cancer Preventorium at MedStar Washington Hospital Center
by Sue Rochman
-
Forward Look
National Clinical Trials Network Now UnderwayRevamped program aims to get new treatments to patients faster.
by Michael Eisenstein
-
Forward Look
Personalizing Prostate Cancer TreatmentActive surveillance may not be right for all African-American men with low-grade prostate cancer.
by Stephen Ornes
-
Lighting a Fire Under Tobacco-Related CancersAs researchers unravel the extent and scientific underpinnings of tobacco-related cancers and addiction, patients can seek support to quit tobacco or cope with the stigma often associated with these cancers.
by Stephen Ornes
-
Telling Cancer’s StoryA Pulitzer Prize-winning book about cancer becomes a documentary after noted filmmaker Ken Burns signs on.
by Marilyn Fenichel
-
When Age Is Only a NumberMore than half of cancer patients are over 65, but not all older cancer patients should be treated alike. That's where geriatric oncology comes in.
by Yasmine Iqbal
-
Healthy Habits
Antioxidant ProtectionTomatoes might play a role in decreasing a man's risk of prostate cancer.
by Leigh Labrie
-
Q&A
Paying Attention to DepressionPsychiatrist Michael Sharpe suggests a new approach to identifying and treating depression in cancer patients.
by Marci A. Landsmann
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
